1 Min Read
May 14 (Reuters) - Brainstorm Cell Therapuetics Inc :
* BRAINSTORM ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE AND CLINICAL HIGHLIGHTS
* Q1 LOSS PER SHARE $0.12 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.